Faculty profile
Pierre-Olivier Gaudreau
Back to facultyResearch
Read how they describe their research on their Queen's University profile.
Latest papers
CRI-CCTG-0003/IND.240 an immunotherapy platform study in platinum-resistant high grade serous ovarian cancer (IPROC): Sub-studies A and B: Durvalumab (D) + mecbotamab vedotin (BA3011) or ozuriftamab vedotin (BA3021).
Cancer treatment and research communications · 2026
Effects of serotonergic drugs on immune checkpoint inhibitor response: a pooled analysis of individual patient data from four Canadian Cancer Trials Group (CCTG) trials
Immunotherapy · 2025 · senior author
Balancing Innovation and Safety: Prediction, Prevention, and Management of Pneumonitis in Lung Cancer Patients Receiving Novel Anti-Cancer Agents.
Cancers · 2025
10 publications.
CRI-CCTG-0003/IND.240 an immunotherapy platform study in platinum-resistant high grade serous ovarian cancer (IPROC): Sub-studies A and B: Durvalumab (D) + mecbotamab vedotin (BA3011) or ozuriftamab vedotin (BA3021).
MacKay HJ, Tinker AV, Nelson BH, Zamarin D, Odunsi AO, Lheureux S, Ellard S, Smrke A, Gaudreau PO, Faulkner T, Upadhaya S, Zhou A, Tu W, Dancey J
Effects of serotonergic drugs on immune checkpoint inhibitor response: a pooled analysis of individual patient data from four Canadian Cancer Trials Group (CCTG) trials
Coschi CH, Ding K, Tu D, O’Callaghan C, Leighl NB, Vera-Badillo F, Juergens RA, Hao D, Seymour L, Renouf DJ
Balancing Innovation and Safety: Prediction, Prevention, and Management of Pneumonitis in Lung Cancer Patients Receiving Novel Anti-Cancer Agents.
Liu S, Wang D, Robinson A, Mates M, Li Y, Chooback N, Gaudreau PO, Digby GC, Fung AS, Genta S
Brief Report: Real-World Eligibility for Clinical Trials in Patients With Extensive-Stage SCLC at a Tertiary Care Center.
Dehar N, Meem M, Aggarwal I, Hopman W, Gaudreau PO, Robinson A, Fung AS
An assessment of extended pembrolizumab dosing in advanced non-small-cell lung cancer in the COVID-19 pandemic.
Moffat GT, Hanna L, Hopman W, Fung AS, Gaudreau PO
Prospective Evaluation of Fetal Hemoglobin Expression in Maternal Erythrocytes: An Analysis of a Cohort of 345 Parturients.
Blain L, Watier C, Weng X, Masse A, Bédard MJ, Bettache N, Weber F, Mahone M, Forté S, Lavallée VP, Gaudreau PO, Newmarch MJ, Soulières D
A study of the efficacy and toxicity outcomes of extended durvalumab dosing in patients with stage III unresectable non-small cell lung cancer (NSCLC) during the COVID-19 pandemic.
Hanna L, Moffat GT, Hopman W, Gaudreau PO, Fung AS
Optimal CCN4 Immunofluorescence for Tissue Microarray
Pierre-Olivier Gaudreau, Isabelle Cousineau, John Stagg
A phase I/II study of pembrolizumab in combination with nab-paclitaxel in patients with unresectable stage III or stage IV non small-cell lung carcinoma (NSCLC).
Nassabein R, Gaudreau PO, Belkaid W, Florescu M, Blais N
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response.
Spencer CN, McQuade JL, Gopalakrishnan V, McCulloch JA, Vetizou M, Cogdill AP, Khan MAW, Zhang X, White MG, Peterson CB, Wong MC, Morad G, Rodgers T, Badger JH, Helmink BA, Andrews MC, Rodrigues RR, Morgun A, Kim YS, Roszik J, Hoffman KL, Zheng J, Zhou Y, Medik YB, Kahn LM, Johnson S, Hudgens CW, Wani K, Gaudreau PO, Harris AL, Jamal MA, Baruch EN, Perez-Guijarro E, Day CP, Merlino G, Pazdrak B, Lochmann BS, Szczepaniak-Sloane RA, Arora R, Anderson J, Zobniw CM, Posada E, Sirmans E, Simon J, Haydu LE, Burton EM, Wang L, Dang M, Clise-Dwyer K, Schneider S, Chapman T, Anang NAS, Duncan S, Toker J, Malke JC, Glitza IC, Amaria RN, Tawbi HA, Diab A, Wong MK, Patel SP, Woodman SE, Davies MA, Ross MI, Gershenwald JE, Lee JE, Hwu P, Jensen V, Samuels Y, Straussman R, Ajami NJ, Nelson KC, Nezi L, Petrosino JF, Futreal PA, Lazar AJ, Hu J, Jenq RR, Tetzlaff MT, Yan Y, Garrett WS, Huttenhower C, Sharma P, Watowich SS, Allison JP, Cohen L, Trinchieri G, Daniel CR, Wargo JA
Frequent collaborators
- Lesley Seymour and Dongsheng Tu: 59 shared papers
- Rosalyn Juergens and Lesley Seymour: 12 shared papers
- Courtney Heather Coschi and Lesley Seymour: 9 shared papers
- Rosalyn Juergens and Dongsheng Tu: 8 shared papers
- Rosalyn Juergens and Normand Blais: 8 shared papers
- Lesley Seymour and Keyue Ding: 7 shared papers
- Rosalyn Juergens and Courtney Heather Coschi: 6 shared papers
- Courtney Heather Coschi and Dongsheng Tu: 5 shared papers
- Lesley Seymour and Normand Blais: 5 shared papers
- Janet Dancey and Lesley Seymour: 4 shared papers
- Dongsheng Tu and Normand Blais: 4 shared papers
- Christopher O'Callaghan and Dongsheng Tu: 3 shared papers
- Rosalyn Juergens and Keyue Ding: 2 shared papers
- Janet Dancey and Dongsheng Tu: 2 shared papers
- Janet Dancey and Wei Tu: 2 shared papers
- Michèle Mahone and Florence Weber: 2 shared papers
- Rosalyn Juergens and Christopher O'Callaghan: 1 shared paper
- Rosalyn Juergens and Pierre-Olivier Gaudreau: 1 shared paper
- Courtney Heather Coschi and Christopher O'Callaghan: 1 shared paper
- Courtney Heather Coschi and Keyue Ding: 1 shared paper
- Courtney Heather Coschi and Pierre-Olivier Gaudreau: 1 shared paper
- Janet Dancey and Pierre-Olivier Gaudreau: 1 shared paper
- Lesley Seymour and Wei Tu: 1 shared paper
- Lesley Seymour and Pierre-Olivier Gaudreau: 1 shared paper
- Christopher O'Callaghan and Pierre-Olivier Gaudreau: 1 shared paper
- Dongsheng Tu and Wei Tu: 1 shared paper
- Dongsheng Tu and Pierre-Olivier Gaudreau: 1 shared paper
- Wei Tu and Pierre-Olivier Gaudreau: 1 shared paper
- John Stagg and Pierre-Olivier Gaudreau: 1 shared paper
- John Stagg and Normand Blais: 1 shared paper
- Keyue Ding and Pierre-Olivier Gaudreau: 1 shared paper
- Negar Chooback and Pierre-Olivier Gaudreau: 1 shared paper
- Negar Chooback and Yuchen Li: 1 shared paper
- Negar Chooback and Mihaela Mates: 1 shared paper
- Pierre-Olivier Gaudreau and Yuchen Li: 1 shared paper
- Pierre-Olivier Gaudreau and Mihaela Mates: 1 shared paper
- Pierre-Olivier Gaudreau and Nazila Bettache: 1 shared paper
- Pierre-Olivier Gaudreau and Normand Blais: 1 shared paper
- Pierre-Olivier Gaudreau and Michèle Mahone: 1 shared paper
- Pierre-Olivier Gaudreau and Florence Weber: 1 shared paper
- Yuchen Li and Mihaela Mates: 1 shared paper
- Nazila Bettache and Michèle Mahone: 1 shared paper
- Nazila Bettache and Florence Weber: 1 shared paper
- Department of Oncology
- Département de médecine
- Department of Public Health Sciences
- Department of Mathematics and Statistics
- Goodman Cancer Institute, Microbiology and Immunology
- Other
Co-authors at Queen's University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Yuchen Li
Department of Oncology
1 shared papers, latest 2025
Mihaela Mates
Department of Oncology
1 shared papers, latest 2025
Nazila Bettache
Département de médecine
1 shared papers, latest 2023
Normand Blais
Département de médecine
1 shared papers, latest 2021
Michèle Mahone
Département de médecine
1 shared papers, latest 2023
Florence Weber
Département de médecine
1 shared papers, latest 2023
Rosalyn Juergens
Department of Oncology
1 shared papers, latest 2025
Courtney Heather Coschi
Department of Oncology
1 shared papers, latest 2025
Janet Dancey
Department of Oncology
1 shared papers, latest 2026
Lesley Seymour
Department of Oncology
1 shared papers, latest 2025
Christopher O'Callaghan
Faculty
1 shared papers, latest 2025
Dongsheng Tu
Department of Mathematics and Statistics
1 shared papers, latest 2025
Wei Tu
Department of Public Health Sciences
1 shared papers, latest 2026
John Stagg
Goodman Cancer Institute, Microbiology and Immunology
1 shared papers, latest 2022
Keyue Ding
Department of Public Health Sciences
1 shared papers, latest 2025
Negar Chooback
Department of Oncology
1 shared papers, latest 2025
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.